OrbusNeich has announced that Genous stent has attained positive clinical and safety outcomes in a 12-month follow-up data in patients discontinuing dual antiplatelet therapy (DAPT) at 30 days and at six months.

Read the rest here:
OrbusNeich Genous stent reports positive data in DAPT patients